by Patrice D. Cani
Gut microbiota, with its close links to metabolism and the immune system, could potentially be a factor that lies at the core of good health. This means it can be positioned at the heart of the processes that influence the risk of contracting different diseases.
by GMFH Editing Team
The Mediterranean dietary pattern has been largely associated with improved health outcomes. Two new randomized controlled trials reveal the contribution of gut microbiome composition and functions to explaining the potential beneficial effects of the Mediterranean diet.
Large inter-individual variability exists regarding how our gut microbiota responds to dietary intervention. New findings in mice and people with obesity show that ‘responders’ to inulin may be identifiable from their gut microbiota before they receive the intervention.
by Andreu Prados
Our gut microbiota profile may help us understand the contribution of bariatric surgery to weight loss. New findings reveal gut microbiota composition before Roux-en-Y gastric bypass is associated with type 2 diabetes remission in obese diabetic women.
by GMFH Editing Team
A large proportion of the general population struggle with digestive symptoms that cannot be detected by conventional diagnostic methods. Understanding how the gastrointestinal tract responds to meal-related stimuli may help both in healthy conditions and in eating-related disorders.
by GMFH Editing Team
Important scientific progress has been made in 2019 in our understanding of the contribution of gut microbiome in health and disease. Have a look at this “2019 Year at a glance” report and discover the year’s breakthroughs in the field.
by GMFH Editing Team
Gibson and Roberfroid were the first to anticipate that probiotics and prebiotics could be combined as synbiotics back in 1995. Mary Ellen Sanders and Andreu Prados introduce our new selection of human research on the health benefits of synbiotics.
by GMFH Editing Team
Could people become drunk without touching any booze? A K. pneumoniae strain with the ability to produce alcohol endogenously has been identified as a novel culprit that may accelerate the development of non-alcoholic fatty liver disease.
by GMFH Editing Team
Ruling out the specific contribution of obesity and type 2 diabetes in gut microbiome variation is a challenge. Louise Thingholm and colleagues have found that while obesity is linked to gut microbiome variation, gut microbiome associations with type 2 diabetes are modest.
by Andreu Prados
Small intestinal damage is a known side effect of nonsteroidal anti-inflammatory drugs. A new double-blind, placebo-controlled study has found that the probiotic Bifidobacterium breve Bif195 may alleviate Aspirin-induced ulcers in healthy adults.